| Bioactivity | HSP70/SIRT2-IN-2 (Compounds 1a) is a dual inhibitor for SIRT2 and HSP70, with IC50 of 45.1±5.0 μM for SIRT2. HSP70/SIRT2-IN-2 has antitumor activity[1]. |
| Name | HSP70/SIRT2-IN-2 |
| CAS | 1796557-72-6 |
| Formula | C17H13N3S3 |
| Molar Mass | 355.50 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Elena Abbotto, et al. Novel Thiazole-Based SIRT2 Inhibitors Discovered via Molecular Modelling Studies and Enzymatic Assays. Pharmaceuticals (Basel). 2023 Sep 18;16(9):1316. |
HSP70/SIRT2-IN-2
CAS: 1796557-72-6 F: C17H13N3S3 W: 355.50
HSP70/SIRT2-IN-2 (Compounds 1a) is a dual inhibitor for SIRT2 and HSP70, with IC50 of 45.1±5.0 μM for SIRT2. HSP70/SIR
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.